Specific-pathogen-free pigs as an animal model for studying Chlamydia trachomatis genital infection by Vanrompay, Daisy et al.
INFECTION AND IMMUNITY, Dec. 2005, p. 8317–8321 Vol. 73, No. 12
0019-9567/05/$08.000 doi:10.1128/IAI.73.12.8317–8321.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Specific-Pathogen-Free Pigs as an Animal Model for Studying
Chlamydia trachomatis Genital Infection
Daisy Vanrompay,1* Thi Q. T. Hoang,1 Liselotte De Vos,1 Kristel Verminnen,1
Taher Harkinezhad,1 Koen Chiers,2 Servaas A. Morre´,3 and Eric Cox4
Department of Molecular Biotechnology, Ghent University, Ghent, Belgium1; Department of Pathology, Bacteriology, and
Poultry Disease, Ghent University, Merelbeke, Belgium2; Laboratory of Immunogenetics, VU University Medical Centre,
Amsterdam, The Netherlands3; and Department of Virology, Parasitology, and Immunology, Ghent University,
Merelbeke, Belgium4
Received 22 October 2004/Returned for modification 16 December 2004/Accepted 16 August 2005
The purpose of the present study was to evaluate pigs as a large-animal model for female genital infection
with two Chlamydia trachomatis human serovar E strains. Sixteen-week-old specific-pathogen-free female pigs
(gilts) were intravaginally infected with the trachoma type E reference strain Bour or the urogenital serovar
E strain 468. Several conclusions can be drawn from our findings on the pathogenicity of a primary
C. trachomatis genital infection in gilts. First of all, we demonstrated that the serovar E strains Bour and 468
could ascend in the genital tract of gilts. The serovar E strains could replicate in the superficial columnar
cervical epithelium and in the superficial epithelial layer of the uterus, which are known to be the specific target
sites for a C. trachomatis genital infection in women. Second, inflammation and pathology occurred at the
replication sites. Third, the organisms could trigger a humoral immune response, as demonstrated by the
presence of immunoglobulin M (IgM), IgG, and IgA in both serum and genital secretion samples. Our findings
imply that the pig model might be useful for studying the pathology, pathogenesis, and immune response to a
C. trachomatis infection of the genital system.
Chlamydia trachomatis continues to be the most common
cause of sexually transmitted disease in developed countries.
World Health Organization figures estimated that over 90 mil-
lion new cases of C. trachomatis infection occur worldwide
each year. C. trachomatis infection of the genital tract often
results in pelvic inflammatory disease, ectopic pregnancy,
chronic pelvic pain, epididymitis, and infant pneumonia (20).
C. trachomatis genital tract infections may also increase the
risk for human immunodeficiency virus infection (9). Differ-
ences in clinical courses of infection, resulting in either symp-
tomatic or asymptomatic infections, are observed. Bacterial
and host factors are believed to contribute to these differences
in clinical courses, although further research is needed (11).
So far, no vaccine has been available, but studies that may
lead to the development of a highly warranted vaccine have
been performed. The first attempt to vaccinate children with a
whole-cell vaccine initially resulted in protection, but the pro-
tection was short-lived. In animal models, whole-cell vaccina-
tion resulted in hypersensitivity reactions, so new strategies
were devised. The first immunogenic molecule described was
the major outer membrane protein, and this molecule has
therefore been studied in great detail as a candidate vaccine.
Even though complete protection was not obtained, reduced
shedding was observed, and vaccine trials in animal models
using naked DNA as a vaccine resulted in stimulation of both
the humoral and the cellular immune responses, indicating
progress in vaccine development (3).
A pig model of infection would be helpful both for vaccine
studies and for studies on major determinants of C. trachomatis-
mediated pathogenesis. Pigs are physiologically and genetically
closely related to humans (1, 21), and sampling is easy in this
large-animal model. Moreover, Tuggle et al. (2003) (21) pro-
duced cDNA libraries containing the majority of genes expressed
in major porcine female reproductive tissues and subsequently
confirmed the broad expression of many genes ubiquitously ex-
pressed in human genital tissues. Thus, the purpose of the present
study was to evaluate pigs as a large-animal model for infection
with C. trachomatis serovar E, which is the most prevalent serovar
(11) isolated from genital tract infections.
MATERIALS AND METHODS
Chlamydia trachomatis strains and culture. The trachoma type E strain Bour
(ATCC VR-348B) (6) and a serovar E genital isolate (468) from a female patient
with a symptomatic clinical course both in her and in her partner (11) were
propagated in cycloheximide-treated HeLa cells by using standard techniques.
Elementary bodies (EBs) were purified and titrated as described elsewhere (22).
Pig model. Fifteen 13-week-old specific-pathogen-free (SPF) outbred female
pigs (gilts) (Intervet Akzo Nobel) were randomly assigned to three groups (A to
C) of five, each reared in separate isolation units. At 16 weeks of age, all groups
were anesthetized by intramuscular injection of Zoletil 100 (Virbac) in 2%
xylazine (VMD). Subsequently, groups A and B were infected by intravaginal
injection of a 50% tissue culture infective dose (1  108 cells) of C. trachomatis
strain 468 or strain Bour, respectively. The noninfected controls were inoculated
with sucrose-phosphate transport medium (2-SP). All gilts were sacrificed at 21
days postinfection (p.i.). Clinical signs were monitored every other day, and body
temperatures were measured weekly. Vaginal swab samples in 1 ml 2-SP for
chlamydial isolation as well as in 1 ml phosphate-buffered saline for mucosal
antibody determination (pH 7.3) were collected. Additionally, sera were taken
immediately prior to the infection and on days 7, 14, and 21 p.i. Swab samples for
isolation of C. trachomatis were stored at 70°C, and those for serum antibody
determination were stored at 20°C. At euthanasia, gilts were examined for
gross lesions. Samples of the liver, the spleen, the local lymph nodes, ovaries,
oviducts, uterine horns and corpus, cervix, urethra, and vagina were imbedded in
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Methylcellulose medium and snap-frozen in liquid nitrogen to prepare cryostat
tissue sections. Tissues were fixed in 10% phosphate-buffered formalin for his-
topathology. The Ghent University Ethical Commission approved the experi-
mental design.
Chlamydial antigen detection. Vaginal swab samples were shaken for 1 h at
4°C, centrifuged, and inoculated on HeLa cells grown on 13-mm coverslips in
Chlamydia Trac bottles (International Medical). Chlamydial growth was moni-
tored by use of an IMAGEN immunofluorescence test. Cryostat tissue sections
(10 m) were similarly stained. All slides were examined using confocal laser
scanning microscopy (Radiance 2000MP; Bio-Rad). Positive cells were counted
in five microscopic fields (magnification, 600). The calculated mean was pre-
sented as a score ranging from 0 to 4. A score of 0 indicated that no antigen was
present. Scores of 1 and 2 indicated means of 1 to 5 and 6 to 10 elementary
bodies per five microscopic fields in the absence of inclusions, respectively.
Scores of 3 and 4 represented 1 to 5 and 6 to 10 inclusion-positive cells, respec-
tively.
Antibody determinations. Pig sera were heat inactivated for 30 min at 56°C
and were subsequently pretreated with kaolin to remove background activity
(14). Genital swab samples were shaken for 10 seconds, and serial twofold
dilutions of sera or genital secretion samples were assayed for determinations of
antibody titers by use of enzyme-linked immunosorbent assay plates (Maxisorp;
Nunc) coated with the appropriate concentration of whole C. trachomatis organ-
isms diluted in phosphate-buffered saline (pH 7.4) as described elsewhere (23).
Histopathology. Samples were processed, embedded in paraffin, sectioned at 5
m, and stained with hematoxylin and eosin. All slides were examined micro-
scopically (Leitz), with the observer being unaware of the animal’s infection
status.
Statistical analysis. Statistical calculations were performed by use of SPSS
version 11.0, and calculations for all groups were compared using the Mann-
Whitney rank sum test. A P value of 0.05 was considered to be significant.
RESULTS
Clinical signs and gross lesions. The mean body tempera-
tures of groups A (468) and B (Bour) significantly increased
during the experiment compared to that of noninfected control
group C. Eighty percent of the pigs of group A showed hyper-
emia of the vulva. The same was observed in 60% of the pigs
of group B. At necropsy, severe gross lesions were observed in
60% and 20% pigs of groups A and B, respectively, and these
pigs showed hyperemia of the vagina; severe congestion and
edema of the uterine wall; large amounts of clear watery uter-
ine contents; severe congestion of the upper genital tract, the
mesovarium, and the urethra; and enlarged local draining
lymph nodes. The remaining 40% and 80% animals of groups
A and B, respectively, showed similar but less prominent le-
sions. Negative controls showed no significantly elevated body
temperatures or other clinical signs or gross lesions.
C. trachomatis vaginal excretion. Fig. 1 shows the results of
the vaginal cultures at days 7, 14, and 21 p.i. Shedding was
consistently, but not extraordinarily, high for group B (Bour).
Shedding was enhanced for group A (468) during the experi-
ment, so that the median scores for vaginal shedding on day 14
(P  0.05) and 21 (P  0.03) p.i. were significantly higher than
those for group B. Vaginal swab samples of all pigs taken
before the infection were negative, and those of group C re-
mained negative throughout the experiment.
Detection in urogenital tissues. Fig. 2 shows the individual
scores for the presence or replication of chlamydiae in the
urogenital tract of infected gilts at 21 days p.i. All tissue sam-
ples from noninfected gilts of group C were negative, as were
the spleen, the liver, and the local draining lymph nodes of
groups A (468) and B (Bour). Gilts of groups A and B showed
comparable, large numbers of EBs and chlamydial inclusions
in the vagina. However, chlamydiae were absent in the urethra
of group B, while EBs and/or urethral inclusions were observed
for group A. Remarkably, the level of cervical replication for
group B was significantly higher than that for group A (P 
0.007), while replication levels in the uterine corpus and uter-
ine horns were comparable. Although EBs were present in the
upper genital tract of all gilts of group B, chlamydial replica-
tion was not observed in tissues beyond the uterine corpus,
except for one right uterine horn. In contrast, three of five gilts
of group A (468) showed an ascending infection with chlamyd-
ial replication in the uterine horn or oviducts. In addition, the
overall level of EBs in the upper genital tract was higher for
group A, and for the left oviduct, a significant difference was
observed (P  0.03).
Antibody detection. Antibody titers in sera and genital se-
cretion samples of infected gilts of group A were present at 7
days p.i. (Table 1). For group B, serum immunoglobulin M
(IgM), IgG, and IgA, as well as mucosal IgM, were also ob-
served at 7 days p.i. Mucosal IgG and IgA in this group ap-
peared at 14 days p.i. Serum IgM (P  0.01), IgG (P  0.01),
and IgA (P  0.05 at day 7 p.i. and P  0.01 at days 14 and
FIG. 1. Chlamydia trachomatis in vaginal secretion samples. Aster-
isks indicate statistically significant differences (P  0.05) between
group A (468) and group B (Bour). Control group C remained nega-
tive throughout the experiment.
FIG. 2. Detection of C. trachomatis in urogenital tract tissues at day
21 p.i. Asterisks indicate statistically significant differences (P  0.05)
between group A (468) and group B (Bour). Filled bars indicate
replication or the presence of inclusions, while empty bars indicate the
presence of EBs.
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21 p.i.) titers in both infected groups were always significantly
different from those of the control group. The same was true
for the mucosal antibody titers, except for those for IgG and
IgA and for IgM, IgG, and IgA at 7 days p.i. in 468- and
Bour-infected gilts, respectively. Significant differences (P 
0.05) in antibody titers between both infected groups were
observed only for mucosal IgG and IgA at 14 and 21 days p.i.,
respectively. Significant differences in serum and mucosal an-
tibody titers within an infected group are presented in Table 1.
Noninfected pigs of control group C had undetectable chla-
mydial antibody titers in both sera and vaginal secretion at the
lowest serum dilution used (1/80).
Histopathology. Histopathology (Table 2; Fig. 3) of genital
specimens of group A was the most severe of the three groups,
and results were comparable within the group. All gilts showed
marked lesions in the vagina, which were characterized by
multifocal intracellular edema together with vacuolar degen-
eration and cell death indicative of apoptosis (chromatin frag-
mentation/condensation and/or cellular shrinkage and frag-
mentation) of epithelial surface cells. At those specific sites,
exfoliated apoptotic-like cells, neutrophils, and lymphocytes
formed a siege on the epithelium. The propria showed perivas-
cular and diffuse infiltration of neutrophils and lymphocytes.
The cervix and the uterus showed few lymphocytes in the
epithelium and diffuse infiltration of neutrophils, lymphocytes,
and plasma cells in the submucosa. The oviducts of three of
five gilts showed few lymphocytes in the lamina propria. The
ovaries showed no histopathological changes. Histopathologi-
cal lesions for group B were less prominent overall and differed
more in severity between animals. Specimens of the negative
control group C, as well as the spleen, the liver, and the local
draining lymph nodes of animals of groups A and B, showed no
histopathological changes.
DISCUSSION
The purpose of the present study was to evaluate SPF pigs as
a large-animal model for female genital infection with C. tra-
chomatis, a strict pathogen of oculogenital epithelial cells.
Current C. trachomatis animal models use the pig-tailed
macaque and the mouse (10). Pigs have never been used,
although pigs are physiologically and genetically highly related
to humans. Pigs are susceptible hosts for Chlamydiaceae, which
cause clinically unapparent infections but are also associated
with a wide variety of disease syndromes, including encepha-
litis, conjunctivitis, enteritis, pneumonia, polyarthritis, and re-
productive disorders. Pigs are naturally infected with Chlamy-
dophila abortus, Chlamydophila pecorum, and Chlamydia suis.
The latter species is phylogenetically related to human C. tra-
chomatis strains.
Dominant C. trachomatis urogenital serovars in the Western
world are D, E, and F, with serovar E being the most prevalent
serovar associated with either symptomatic or asymptomatic
courses of infection (13, 20, 24). Therefore, we used two sero-
var E strains in this study. The trachoma type E strain Bour
(ATCC VR-348B) was isolated in 1959 from an adult with
clinical inclusion conjunctivitis (6). Although isolated from the
eye, the Bour strain caused genital infection in animal models
of vaccination (15, 16). Strain 468 was isolated from a female
patient and had a symptomatic clinical course of infection in
both the patient and her partner (11). Strain 468 caused mu-
copurulent vaginal discharge and lower abdominal pain in the
female patient and dysuria and mucous discharge in the male
partner.
Pigs of Western origin, such as the ones used at present,
have a period of antral follicular development at around 70 to
90 days of age, which is followed by a period of ovarian qui-
escence (17). Most follicles undergo atresia, but those whose
final maturation coincides with onset of estrus will ovulate.
Activation and growth of primordial follicles occur continu-
ously throughout the life of the gilt or sow, which is necessary
because the time course of follicular development is quite long.
Thus, the follicle that ovulates when the gilt reaches puberty at
180 days (26 weeks) of age actually started growing more than
three months earlier (2). Thus, although pigs do not have a real
anestrous phase like that of mice, the age of ovarian quies-
cence from 13 weeks of age until 26 weeks of age can be
considered as an anestrous condition. Therefore, 13-week-old
SPF pigs in the anestrous phase of the estrous cycle could be
used as well as sows of 26 weeks of age during the luteal phase
of the estrous cycle. In the present study, we chose to use
16-week-old gilts, as 13-week-old ones may still have Chlamy-
diaceae-specific maternal antibodies, while 26-week-old sows
are more difficult to manipulate.
No clinical signs of a C. trachomatis infection were observed,
except for a reddish vulva and fever. The latter has also been
TABLE 1. Serum and vaginal secretion antibody titers of pigs infected with C. trachomatis strains 468 or Bour
Strain Day p.i.
Median titer (range from lowest to highest) of isotype-specific antibody for:
Serum isotype Mucosal isotype
IgM IgG IgA IgM IgG IgA
468 7 2,560 (1,280–2,560)a,d 160 (80–320)a,d 80 (80–320)b 80 (80–160)b,d 80 (80–80) 80
14 1,280 (640–2,560)a 1280 (640–1,280)a,e 160 (160–320)a,d 800 (400–1,600)a 1,600 (800–3,200)a,c,e 800 (400–1,600)a,d
21 640 (640–2,560)a 640 (640–1,280)a,e 160 (80–160)a,d 800 (400–800)a 1,600 (800–3,200)a,e 800 (800–1,600)a,c,d
Bour 7 2,560 (1,280–2,560)a,d 160 (80–320)a,d 80 (80–160)b 80 (80–80) 80 80
14 1,280 (640–2,560)a 640 (320–1,280)a 160 (80–320)a,d 800 (400–800)a 800 (200–1,600)a,e 400 (200–800)a, d
21 960 (640–2,560)a,e 640 (320–1,280)a 80 (80–160)a,d 300 (200–800)a,e 800 (200–1,600)a 300 (200–800)a,c,d
a P value was 0.01 for differences in the isotype-specific antibody titers between the infected groups and the control group.
b P value was 0.05 for differences in the isotype-specific antibody titers between the infected groups and the control group.
c P value was 0.05 for differences between the isotype-specific antibody titers for the 468-and Bour-infected groups.
d P value was 0.01 for differences between isotype-specific antibody titers in serum and vaginal secretions within one group.
e P value was 0.05 for differences between isotype-specific antibody titers in serum and vaginal secretions within one group.
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described for women (4, 5). At autopsy, group A (468) showed
lesions of greater severity than group B (Bour) did, although
most prominent gross lesions for both groups could be ob-
served in the cervix and the uterus of all gilts euthanized at 21
days p.i. The observed inflammation and edematous thickened
cervical and uterine wall was also present in women with acute
C. trachomatis salpingitis (12).
Chlamydial excretion was observed in all gilts examined at 7,
14, and 21 days p.i. At 21 days p.i., vaginal excretion for group
A was significantly higher than that for group B. A possible
explanation could be the additional replication of strain 468 in
the urethra; strain Bour, on the other hand, was undetectable
in the urethra. Strain Bour was present mainly in epithelial
cells of the lower genital tract, with clear replication in the
vagina and the cervix, while strain 468 was found more often in
epithelial cells throughout the urogenital tract and even repli-
cated in the oviducts. Thus, experimental inoculations resulted
in an ascending infection, although strain 468 ascended faster
and probably more intensely than strain Bour. However, the
latter was not proven, as all animals were sacrificed at 21 days
p.i. The ascending character of the infection has also been
found to be present in guinea pigs, mice, and humans (11, 19).
There was no replication outside the genital tract. This is in
accordance with the literature stating that only lymphogranu-
loma venereum strains, being biologically and pathologically
distinct from the strains of serovars D to K, invade the sub-
mucosa to infect macrophages and disseminate to regional
lymph nodes (7).
Both serovar E strains caused acute inflammatory infiltra-
tions in the uterus and oviducts. Uterine edema and cell vac-
uolization as well as oviduct cell vacuolization and hyperplasia
were observed. Lesions were similar to those observed by
Ramsey et al. (2000) (18) following a primary murine intra-
vaginal infection with a C. trachomatis serovar E strain.
The infection resulted in antibodies in sera and genital se-
cretion samples. At 14 days p.i., mucosal IgA titers, likely to be
synthesized locally in the genital tract, were significantly higher
than those observed in the sera. This is consistent with the
FIG. 3. Photomicrographs of vagina, uterine corpus, and uterine horn tissue sections. All sections were stained with hematoxylin and eosin and
visualized microscopically (magnification,400). (A) Typical uninfected vaginal morphology. (B) Inflammation of the vagina of a 468-infected gilt
of group A. Note the presence of apoptotic-like cells above the epithelial layer (arrows) as well as few cells with intracellular edema in the epithelial
layer. (C) Cervix of a Bour-infected gilt of group B. Note the diffuse infiltration of lymphocytes. (D) Uterine horn of a 468-infected gilt. Note the
strongly folded epithelial layer with transmigrating lymphocytes and neutrophils (arrow A). The lamina propria shows focal infiltration of
inflammatory cells and congestion of the blood vessels (arrow B).
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observation of Kozlowski et al. (2000) (8). Mucosal antibody
titers for group A were not significantly higher than those for
group B.
In conclusion, we demonstrated that serovar E strains Bour
and 468 could ascend in the genital tract of gilts. Both strains
replicated in the superficial epithelial cervical and uterine lay-
ers, which are known to be target sites for a C. trachomatis
genital infection. Inflammation and pathology occurred at the
replication sites, and the organisms could trigger antibody re-
sponses. Our findings imply that the pig may be useful for
studying the pathology, pathogenesis, and immune response of
a C. trachomatis genital infection.
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TABLE 2. Severities of histopathology and percent positive
pigs in infected groups A and B
Location of
histopathological
lesions
Description
Severity of histopathology
(% positive pigs) in
infected group (n  5)a
A B
Vagina Edema  (100)  (40)
Vacuolar degeneration  (100)  (40)
Epithelial apoptosis  (100)  (40)
Infiltration of neutrophils  (100)  (100)
Infiltration of lymphocytes  (100)  (100)
Infiltration of plasma cells  (100)  (100)
Cervix Congestion  (100)  (100)
Infiltration of neutrophils  (100)  (60)
Infiltration of lymphocytes  (100)  (60)
Infiltration of plasma cells  (100)  (60)
Uterus Congestion  (100)  (40)
Infiltration of neutrophils  (100)  (60)
Infiltration of lymphocytes  (100)  (60)
Infiltration of plasma cells  (100)  (60)
Oviducts Focal epithelial vacuolization  (0)  (40)
Infiltration of lymphocytes  (60)  (40)
Infiltration of plasma cells  (0)  (40)
a , no lesions; , slight lesions; , moderate lesions; , severe lesions.
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